why choose us

First received: January 16, 2026

Clinical Trial: An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants
Pharmacokinetic Study

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of AGA2118 in Healthy Japanese, Chinese, and Caucasian Participants

Brief Summary: This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants

Read more